These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2577412)

  • 41. Relationship between effluent levels of beta(2)-microglobulin and peritoneal injury markers in 7.5% icodextrin-based peritoneal dialysis solution.
    Minami S; Hora K; Kamijo Y; Higuchi M
    Ther Apher Dial; 2007 Aug; 11(4):296-300. PubMed ID: 17661836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis.
    Neal D; Bailie GR
    Clin Pharmacokinet; 1990 Jun; 18(6):485-90. PubMed ID: 2354591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Free choline and phospholipid-bound choline concentrations in serum and dialysate during peritoneal dialysis in children and adults.
    Ilcol YO; Dönmez O; Yavuz M; Dilek K; Yurtkuran M; Ulus IH
    Clin Biochem; 2002 Jun; 35(4):307-13. PubMed ID: 12135694
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beta 2-microglobulin amyloidosis in a patient treated exclusively by continuous ambulatory peritoneal dialysis.
    Jadoul M; Noel H; van Ypersele de Strihou C
    Am J Kidney Dis; 1990 Jan; 15(1):86-8. PubMed ID: 2403753
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beta 2-microglobulin synthesis of mononuclear cells in chronic dialysis patients.
    Kumano K; Nanbu M; Kusakari S; Sakai T
    Int J Artif Organs; 1992 Jul; 15(7):401-7. PubMed ID: 1516990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of CAPD and residual diuresis on the serum levels of alpha-1-microglobulin in end-stage renal disease.
    Weber MH; Reetze P; Neumann F; Warneke G; Scheler F
    Nephron; 1989; 51(3):367-9. PubMed ID: 2465498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantification of beta 2-microglobulin and albumin in plasma and peritoneal dialysis fluid by a noncompetitive immunoenzymometric assay.
    Kandoussi A; Cachera C; Pagniez D; Saile R; Tacquet A
    Clin Chem; 1993 Jan; 39(1):93-6. PubMed ID: 8419067
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simplified peritoneal equilibration test in CAPD.
    Selçuk NY; Tonbul HZ; Capoğlu I; San A
    Nephron; 1998 Sep; 80(1):109-10. PubMed ID: 9730726
    [No Abstract]   [Full Text] [Related]  

  • 49. An outpatient maneuver to treat bloody effluent during continuous ambulatory peritoneal dialysis (CAPD).
    Goodkin DA; Benning MG
    Perit Dial Int; 1990; 10(3):227-9. PubMed ID: 2094462
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spurious estimations of sodium removal during CAPD when [Na](+) is measured by Na electrode methodology.
    La Milia V; Di Filippo S; Crepaldi M; Andrulli S; Marai P; Bacchini G; Del Vecchio L; Locatelli F
    Kidney Int; 2000 Nov; 58(5):2194-9. PubMed ID: 11044241
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Charge-affected transperitoneal movement of amino acids in CAPD.
    Nakao T; Ogura M; Takahashi H; Okada T
    Perit Dial Int; 1996; 16 Suppl 1():S88-90. PubMed ID: 8728170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What effect does glucose have on measured creatinine in the peritoneal equilibration test?
    Prowant BF; Schmidt LM
    ANNA J; 1991 Apr; 18(2):221. PubMed ID: 2025055
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical significance of a dialysis membrane that can remove beta 2-microglobulin (beta 2m).
    Ono T; Iwamoto N; Kataoka H; Yamada S; Sakai Y; Kunitomo T
    ASAIO Trans; 1988; 34(3):342-5. PubMed ID: 3058179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor necrosis factor, interleukin-1 and beta 2-microglobulin levels in chronic hemodialysis patients.
    Caruana RJ; Lobel SA; Leffell MS; Campbell H; Cheek PL
    Int J Artif Organs; 1990 Dec; 13(12):794-8. PubMed ID: 2289831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kinetics of 125I-beta 2-microglobulin turnover in dialyzed patients.
    Vincent C; Chanard J; Caudwell V; Lavaud S; Wong T; Revillard JP
    Kidney Int; 1992 Dec; 42(6):1434-43. PubMed ID: 1474777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beta 2 microglobulin in kidney failure: A review and an algorithm for renal replacement therapy.
    Assounga AG
    Saudi J Kidney Dis Transpl; 2021; 32(5):1214-1220. PubMed ID: 35532690
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fasting plasma amino acids are not normalized by 12-month amino acid-based dialysate in CAPD patients.
    Jones CH; Smith M; Henderson MJ; Will EJ; Davison AM; Newstead CG
    Perit Dial Int; 1999; 19(2):174-7. PubMed ID: 10357192
    [No Abstract]   [Full Text] [Related]  

  • 58. Identification, characterization, and quantitation of soluble HLA antigens in the circulation and peritoneal dialysate of renal patients.
    Gelder FB; McDonald JC; Landreneau MD; McMillan RM; Aultman DF
    Ann Surg; 1991 Jun; 213(6):591-7; discussion 597-9. PubMed ID: 2039290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Quantitative determination of the beta-2-microglobulin monomer by gel filtration chromatography].
    Bao X; Ren J; Wang Y; Jia L
    Se Pu; 2019 May; 37(5):533-538. PubMed ID: 31070337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum soluble CD14 levels and ultrafiltered dialysate in hemodialysis patients.
    Nakazawa R; Kaneko M; Hoshi H; Kim T; Nakamura M; Azuma N; Suzuki M
    Nephron; 1996; 73(3):493-4. PubMed ID: 8832619
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.